Emerging concepts for patients with treatment-resistant hypertension
Author:
Funder
NIH
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference42 articles.
1. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010;Lim;Lancet,2012
2. Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda MD, U.S.A., October 10, 2013;White;J Am Soc Hypertens,2014
3. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Eur Heart J,2013
4. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research;Calhoun;Hypertension,2008
5. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT);Muntner;Hypertension,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. L-methionine protects against nephrotoxicity induced by methotrexate through modulation of redox status and inflammation;Redox Report;2023-11-06
2. Predictive Modeling of Resistant Hypertension Risk: Incorporating the TyG Index and Clinical Factors;2023-11-06
3. Hipertensión arterial refractaria al tratamiento. Definiciones y manejo actualizado;LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades;2023-08-21
4. Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT);Vascular Health and Risk Management;2022-12
5. National Hypertension Guidelines: A Review of the India Hypertension Control Initiative (IHCI) and Future Prospects;Cureus;2022-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3